Who owns AMBRX BIOPHARMA INC?
- CUSIP Number: 02290a102
Tip: Access positions for across all investors
Analyze quarterly positions in Ambrx Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ambrx Biopharma stock
Who bought or sold AMBRX BIOPHARMA INC this quarter?
There are no current stakeholders of Ambrx Biopharma.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Ambrx Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Darwin Global Management | Sep 2023 | 17M | $192M |
| Cormorant Asset Management | Sep 2023 | 9.9M | $114M |
| D. E. Shaw & Co | Sep 2023 | 4.0M | $46M |
| Paradigm Biocapital Advisors | Sep 2023 | 3.7M | $43M |
| Commodore Capital | Sep 2023 | 3.5M | $41M |
| Federated Investors | Sep 2023 | 2.4M | $28M |
| VR Adviser | Sep 2023 | 2.1M | $24M |
| Citadel Advisors | Sep 2023 | 907k | $10M |
| T. Rowe Price Associates | Sep 2023 | 822k | $9.4M |
| Millennium Management | Sep 2023 | 607k | $7.0M |
| Holocene Advisors | Sep 2023 | 487k | $5.6M |
| NWI Management | Sep 2023 | 161k | $1.9M |
| Logos Global Management | Sep 2023 | 115k | $1.3M |
| TD Asset Management | Sep 2023 | 111k | $1.3M |
| Dr. Jeffrey R. Jay, M.D. | Sep 2023 | 98k | $1.1M |
| Monashee Investment Management | Sep 2023 | 70k | $805k |
| Simplex Trading | Sep 2023 | 69k | $788k |
| Bank of New York Mellon | Sep 2023 | 47k | $546k |
| Alliancebernstein | Sep 2023 | 47k | $544k |
| ALPS Advisors | Sep 2023 | 46k | $524k |
| Gts Securities | Sep 2023 | 44k | $511k |
| Apis Capital Advisors | Sep 2023 | 34k | $391k |
| Hillhouse Capital Advisors | Sep 2023 | 32k | $365k |
| Squarepoint Ops | Sep 2023 | 22k | $255k |
| Virtus ETF Advisers | Sep 2023 | 6.8k | $78k |
| Royal Bank of Canada | Sep 2023 | 6.5k | $75k |
| UBS Group | Sep 2023 | 5.6k | $64k |
| Ikarian Capital | Sep 2023 | 4.9k | $5.7M |
| Legal & General Group | Sep 2023 | 1.4k | $16k |
| Us Bancorp | Sep 2023 | 1.0k | $12k |
| Bank of America Corporation | Sep 2023 | 500.00 | $5.8k |